Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Updates

 Please find enclosed copies of notice published in Newspapers, for the attention of Equity Shareholders of the Company in respect of transfer of Equity Shares to Investor Education and Protection Fund. The notices have been published on April 14, 2017 in Business Standard (English) and Mumbai Lakshadeep (Marathi) in accordance with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 notified by the Ministry of Corporate Affairs (as amended).
17-04-2017
Bigul

Unichem Labs gets USFDA nod for arthritis drug

 Drug firm Unichem Laboratories today said it has received approval from the US health regulator for Piroxicam capsules, used in the treatment of osteoarthritis and rheumatoid arthritis, in the US...
17-04-2017
Bigul

Updates

 Unichem Laboratories Limited is pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg & 20mg, which are therapeutically equivalent to Feldene Capsules 10mg & 20mg of Pfizer, Inc. Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). For the relief...
17-04-2017
Bigul

Certificate Under Regulation 40(9) & 40 (10) Of The SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2017

 Certificate issued by Ragini Chokshi & Associates, Company Secretaries for the year ended March 31, 2017 as required under Regulation 40(9) & 40 (10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
11-04-2017
Bigul

Updates

 Please find enclosed Auditors Certificate regarding allotment money received for 2025 shares allotted to Employee/s of the Company pursuant to the ESOP 2008 Scheme for your record
11-04-2017
Bigul

Shareholding for the Period Ended March 31, 2017

 Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here
11-04-2017
Bigul

Statement Of Investor Complaints For Quarter Ended March 31, 2017

 Pursuant to Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit hereunder the statement of Investor Complaints for the quarter ended March 31, 2017. Particulars No of Complaints Investor Complaints pending at the beginning of the quarter 0 Investor Complaints received during the quarter...
11-04-2017
Bigul

Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period Ended March 31, 2017.

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period October 1, 2016 to March 31, 2017 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share...
10-04-2017
Bigul

Outcome of Board Meeting

 Unichem Laboratories Limited has informed the Exchange that at the Board meeting held on April 1, 2017, the Board has allotted 25,550 Equity Shares under ESOP 2008.
01-04-2017
Bigul

Updates

 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
20-03-2017
Next Page
Close

Let's Open Free Demat Account